Back to search results

Personalised Immunotherapy Platform

Abroad (travel likely)Recruiting

Conditions

Melanoma · Cutaneous Squamous Cell Carcinoma · Basal Cell Carcinoma · Merkel Cell Carcinoma · Solid Tumor

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Chris O'Brien Lifehouse, Sydney, New South Wales, Australia

    Contact: Study coordinator (Michael Boyer, MBBS) · michael.boyer@lh.org.au
    Jenny Lee, MBBS (Sub-investigator)

  • Melanoma Institute Australia, Sydney, New South Wales, Australia

    Contact: Study coordinator (Georgina Long, MBBS) · georgina.long@sydney.edu.au
    Ines Silva, MBBS (Sub-investigator)
    Richard Scolyer, MBBS (Sub-investigator)
    Alexander Menzies, MBBS (Sub-investigator)
    Serigne Lo, PhD (Sub-investigator)
    Anne Cust, PhD (Sub-investigator)
    Rachael Morton, PhD (Sub-investigator)

  • Westmead Hospital, Sydney, New South Wales, Australia

    Contact: Study coordinator (Matteo Carlion, MBBS) · matteo.carlino@sydney.edu.au
Study leads

  • James Wilmott, PhD

    Principal Investigator

    Melanoma Institute Australia

View source on ClinicalTrials.gov(opens in a new tab)